Investors / United States / UVA Licensing & Ventures Group
UVA Licensing & Ventures Group
Investor · Charlottesville, VA, United States · North America
The office manages technology transfer for the University of Virginia, licensing inventions discovered by faculty and researchers to companies. It also supports the formation of ventures based on UVA research and connects researchers with investors and entrepreneurs.
Invests inHealthcare & Biotech
In its own wordstechnology transferuniversity spinoutslife scienceslicensing
Your fit with UVA Licensing & Ventures Group
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsUVA Licensing & Ventures Group lists 34 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (61%), Industrial & Manufacturing (12%) and Education (12%). 100% of its companies are based in United States. It invests most often alongside Osage University Partners, VTC Ventures and ARCH Venture Partners.
No funding round on record names UVA Licensing & Ventures Group yet, so the figures come from its portfolio page.
Round figures show recent activity, not UVA Licensing & Ventures Group's whole history. Rounds on record name 0 companies; its own site lists 34. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 61% | 15% |
| Industrial & Manufacturing | 12% | 7% |
| Education | 12% | 7% |
| AI & Machine Learning | 7% | 18% |
| Consumer | 2% | 3% |
| Robotics & Hardware | 2% | 1% |
| Real Estate & Construction | 2% | 3% |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3294%
- No longer answers00%
- Points to another company26%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 73th | 35 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 89th | 61% in its largest sector |
| Reach | 19th | 1 country |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Osage University Partners
Compare UVA Licensing & Ventures Group head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
34 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adial Pharmaceuticals is developing differentiated therapies for serious immune-mediated and inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| The company creates targeted, non-toxic pest control that is safe for humans and the environment through reliable and affordable bio-based solutions. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Angara helps industrial operators detect, quantify and eliminate heat-transfer degradation through AI-driven analytics and intelligent cleaning technologies | Industrial & Manufacturing | Portfolio page | ||
| BrightSpec develops and provides molecular rotational resonance spectroscopy products and solutions | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Cerillo delivers compact, well-engineered microplate readers designed to fit directly into existing experimental workflows. | Healthcare & Biotech | Portfolio page | ||
| Contraline is a company developing investigational male contraceptive products, including a topical gel and a reversible implant. | Healthcare & Biotech | Portfolio page | ||
| CytoRecovery sells products, including CytoBuffer, and features dielectrophoresis technology for sorting immune cells. | Healthcare & Biotech | Portfolio page | ||
| Dominion Microprobes develops technology for the characterization of mm and submm wave devices | Industrial & Manufacturing | Portfolio page | ||
| EarJellies produces and sells noise-reducing earplugs made from shape-memory silicone. | Healthcare & Biotech | Portfolio page | ||
| Everactive creates self-powered chips for wireless Ambient IoT devices that can sense, process, and wirelessly transmit data continuously using energy harvested from the environment. | Industrial & ManufacturingConsumer | Portfolio page | ||
| HKL Research licenses and supports software widely used in structural biology. | Healthcare & Biotech | Portfolio page | ||
| HTIC develops novel antibody-based biologics for unmet medical needs | Healthcare & Biotech | Portfolio page | ||
| Hyku Biosciences is developing small molecule therapeutics with novel mechanisms of action to potently inactivate proteins that drive disease progression. | Healthcare & Biotech | Portfolio page | ||
| The company provides products and services for allergen testing and research. | Healthcare & Biotech | Portfolio page | ||
| The company discovers and develops novel cancer therapeutics to improve patient outcomes. | Healthcare & Biotech | Portfolio page | ||
| Lytos Technologies is engineering the future of biology, delivering biosolutions that make the world safer, healthier, and cleaner. | Healthcare & Biotech | Portfolio page | ||
| Nouveau Biosciences is pioneering novel technology for developing new drugs rapidly and effectively to treat cancer. | Healthcare & Biotech | Portfolio page | ||
| PS Fertility measures male fertility through sperm competence, specifically by detecting the presence of phosphatidylserine on sperm, which is necessary for fertilization to occur. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- virginia.edu
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 34
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get UVA Licensing & Ventures Group's profile as data
Pull UVA Licensing & Ventures Group's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/virginia.edu
# also
GET /v1/firms/virginia.edu/portfolio
GET /v1/firms/virginia.edu/coinvestors
GET /v1/firms/virginia.edu/news